DOTmed.com - EnteroMedics Makes Russell 3000(R) Index

You can search by:

Equipment Type, Model, Mfg

Part #

Company, Last Name

Service

Job Type

Auction #

Listing #

Other Headlines

House Passes Medicare Physician Payment Reform Act

Advocacy groups applaud passage of bill that would permanently repeal and replace SGR.

Ceremony and Fund for Families of MedEvac Helicopter Crash

The medical community pays tribute to a dedicated crew.

Clinical PET-MRI Moves Closer to Reality

Thanks to a European grant for the HyperIMAGE project, a consortium of scientists across Europe have worked with Philips to develop a proof-of-concept, pre-clinical combined MR-PET scanner that could one day lead to improved radiation therapy and cardiology treatments.

Ingestible Device Monitors GI Tract on the Go

GI monitoring device promises to speed the evaluation and treatment of GI motility disorders.

Interview with Beth Bukata, Assistant Director of Communications for ASTRO

DOTmed discusses the American Society for Therapeutic Radiation Oncology (ASTRO) program for public awareness with ASTRO's assistant director of communications, Beth Bukata.

Have News for Us?

Submit your news on the industry, people, or companies.

Forward to a Friend

More News Headlines

Philips and BrainLAB Partner Real-time road map for neurosurgeons at the Montreal Children's Hospital.

Airgas Acquires Tri-Tech Based in Tampa, Florida Adds 16 locations throughout Florida, Georgia, and South Carolina.

Medical Imaging Holdings, Inc. Changes Name of Operating Company to Unisyn Medical Technologies, Inc. New name for the combined companies of Barrington Medical Imaging, Sonora Medical Systems, and Echoserve.

Varian Medical Systems to Showcase the Latest X-Ray Image Detectors and X-Ray Tubes at the MEDICA 2009 International Trade Fair The MEDICA 2009 International Trade Fair in Dusseldorf, Germany runs November 18-21, 2009.

Journal of Cardiac Failure Has Published Study Results They validate low-intensity exercise method of testing used with New Shape-HF™ Cardiopulmonary Exercise Testing System.

Medtronic Receives FDA Warning Letter Following Inspection of Its Mounds View, Minn. Facility FDA noted that the company's promised corrective actions appear to be adequate to resolve the issues raised in the letter.

New HIMSS Analytics Survey Reveals Healthcare "Business Associates" Unprepared for Data Breach HITECH Act's expanded breach notification requirements will result in more discovery and reporting of incidents.

Carestream Health Signs Contract to Provide Healthcare IT Solutions to MedAssets Customers Carestream Health's Vendor-Neutral Offerings Include Data Archiving, Professional Services, RIS/PACS and New Cardiology PACS.

AMA, Others Call for Reform AMA, AARP, MOAA call for passage of House bill H.R. 3961. to repeal doctor pay formula.

IMIX Americas Introduces News Slimline DR Detectors Thinner detector rounds out state-of-the-art product line.

The Russell's U.S. indexes
annually captures the
4,000 largest U.S. stocks

EnteroMedics Makes Russell 3000(R) Index

July 01, 2009

EnteroMedics, the creator of medical devices using neuroblocking technology, which addresses obesity and other gastrointestinal disorders, has been added to the Russell 3000(R) Index.

The Russell's U.S. index annually captures the 4,000 largest U.S. stocks, ranking them by total market capitalization.

EnteroMedics' membership in the Russell 3000 will remain effective for a year and means that it has automatic inclusion in the small-cap Russell 2000 Index and relevant growth and value indexes. An industry-leading $4 trillion in assets are currently benchmarked to the Russell indexes.

About EnteroMedics Inc.

EnteroMedics is a development stage medical device company focused on the design and development of devices that use neuroblocking technology to treat obesity and other gastrointestinal disorders.

EnteroMedics' proprietary neuroblocking technology, VBLOC(R) vagal blocking therapy, is designed to intermittently block the vagus nerves using high-frequency, low-energy, electrical impulses. EnteroMedics has met its enrollment goal under an FDA-approved Investigational Device Exemption (IDE) for the EMPOWER(TM) Study using the Maestro(R) System, its initial product for the treatment of obesity. EnteroMedics is currently recruiting patients outside of the United States for a feasibility study examining VBLOC Therapy's effects on blood glucose levels in diabetic patients. For more information, visit www.enteromedics.com

Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

Please Send us your Comments.

Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2009 DOTmed.com, Inc.
ALL RIGHTS RESERVED